Recombinant, replication defective CELO virus and CELO virus DNA
US6797506B1 · kind B1 · utility
1Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2000 |
| Grant date | Sep 28, 2004 |
| Priority date | — |
| Expiry date | Jun 13, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10243
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Recombinant CELO virus or CELO virus DNA with a deletion or disruption of the Gam1 gene, optionally combined with deletions at the right or left end of the viral genome that allow insertion of large pieces of foreign DNA. The virus is useful as a vaccine for animals, in particular birds, and for gene therapy and vaccine applications in humans. The virus can also be used for recombinant protein production.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.